Natus Medical Inc (BABY): James B Hawkins , CEO of Natus Medical Inc purchased 10,000 shares on Sep 28, 2016. The Insider buying transaction was reported by the company on Sep 28, 2016 to the Securities and Exchange Commission. The shares were purchased at $38.48 per share for a total value of $384,840.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 28, 2016, Robert A Gunst (director) sold 5,000 shares at $34.61 per share price.On Apr 28, 2016, Doris Engibous (director) sold 5,000 shares at $32.68 per share price.Also, On Apr 28, 2016, Kenneth M Traverso (VP/GM Newborn Care) sold 7,459 shares at $33.56 per share price.On Feb 18, 2016, Ken Ludlum (director) sold 6,625 shares at $33.01 per share price.
Shares of Natus Medical Inc (BABY) ended Tuesday, Sep 27, 2016 session in red amid volatile trading. The shares closed down -0.39 points or -0.98% at $39.32 with 5,44,835 shares getting traded. Post opening the session at $39.48, the shares hit an intraday low of $38.3 and an intraday high of $39.48 and the price vacillated in this range throughout the day. The company has a market cap of $1,296 M and the number of outstanding shares has been calculated to be 3,29,50,790 shares. The 52-week high of Natus Medical Inc is $51.05 and the 52-week low is $29.54.
Company has been under the radar of several Street Analysts.Natus Medical Inc is Upgraded by Raymond James to Outperform. Earlier the firm had a rating of Mkt Perform on the company shares. The Rating was issued on Sep 13, 2016.
Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.